Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyvalent cation chelation describes the ability of certain molecules, known as chelators, to bind and sequester metal ions with multiple positive charges (such as calcium, magnesium, manganese, or aluminum) through the formation of stable ring-like complexes (chelates). This process can profoundly affect biological activity, including enzyme function and assembly of proteins or nucleic acids, and is widely used therapeutically for treating heavy metal poisoning, as well as in laboratory, environmental, and industrial applications. It is not itself a therapeutic target, but rather describes an important chemical interaction with broad biological and pharmacological consequences. If you require information about a specific chelating agent (such as "EDTA"), a specific polyvalent cation (like "Calcium channel"), or a receptor modulated by cation chelation, providing a more specific target name will allow for a structured biological and pharmacological profile.
Chelation of polyvalent cations to either sequester toxic metals, disrupt metal-dependent biological processes, or reduce drug absorption due to insoluble complex formation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyvalent cation chelation.